Similar Search Results

Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany"

Gandjour, Afschin - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 471-472

Persistent link: https://www.econbiz.de/10011952176

Editorial: prioritizing health services research : an economic perspective

Gandjour, Afschin - In: The European journal of health economics : HEPAC ; … 17 (2016) 4, pp. 375-377

Persistent link: https://www.econbiz.de/10011654244

Value-based pricing of a COVID-19 vaccine

Gandjour, Afschin - In: The quarterly review of economics and finance : journal … 84 (2022), pp. 1-8

Persistent link: https://www.econbiz.de/10013334619

Economic evaluation of health-care programmes : is CEA better than CBA?

Gafni, Amiram - In: Environmental & resource economics : the official … 34 (2006) 3, pp. 407-418

Persistent link: https://www.econbiz.de/10003357859

Cost effectiveness utility analyses : do current decision rules lead us to where we want to be?

Birch, Stephen - In: Journal of health economics 11 (1992) 3, pp. 279-296

Persistent link: https://www.econbiz.de/10001136907

NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales

Gafni, Amiram; Birch, Stephen - In: PharmacoEconomics 21 (2003) 3, pp. 149-157

The National Institute for Clinical Excellence (NICE) responds to requests by the Department of Health for guidance on the use of selected new and established technologies in the National Health Service (NHS) in England and Wales. This paper asks whether the NICE methodological guidelines help...

Persistent link: https://www.econbiz.de/10004990353